Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE)
CALIBRATE TRIAL: a Prospective, Single Arm Investigational Clinical Trial Evaluating Safety and Performance of the Free Margin Cusp Sizer During Aortic Valve Repair Surgery
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
120 participants
Mar 22, 2021
INTERVENTIONAL
Conditions
Summary
The objective of this study is to investigate safety and performance of the Free Margin Cusp sizer. The device will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length at different stages of the procedure. The patient will be followed for one year clinically (at 1, 2, 6 and 12 months) and by echocardiography (at 6 and 12 months) to assess aortic valve function.
Eligibility
Inclusion Criteria1
- Patients with Tricuspid Aortic Valve (TAV) operated electively for aortic valve regurgitation and or ascending aorta dilatation.
Exclusion Criteria6
- Acute aortic dissection;
- Diffuse aortic valve calcification;
- AV endocarditis;
- Bicuspid, unicuspid or quadricuspid aortic valves;
- Patients under the age of 18 years;
- Patients above the age of 80 years.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The free margin cusp sizer will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04797572